Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Colorectal Neoplasms

Free Subscription Articles published in Int J Oncol Retrieve available abstracts of 44 articles: HTML format Text format

Single Articles

January 2012
1. FUJISHIMA Y , Goi T, Kimura Y, Hirono Y, et al
   MUC2 protein expression status is useful in assessing the effects of hyperthermic intraperitoneal chemotherapy for peritoneal dissemination of colon cancer.
   Int J Oncol. 2012 Jan 16. doi: 10.3892/ijo.2012.1334.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. ZHUANG Q , Hong F, Shen A, Zheng L, et al
   Pien Tze Huang inhibits tumor cell proliferation and promotes apoptosis via suppressing the STAT3 pathway in a colorectal cancer mouse model.
   Int J Oncol. 2012 Jan 3. doi: 10.3892/ijo.2012.1326.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. MIKI H , Uehara N, Kimura A, Sasaki T, et al
   Resveratrol induces apoptosis via ROS-triggered autophagy in human colon cancer cells.
   Int J Oncol. 2012 Jan 3. doi: 10.3892/ijo.2012.1325.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. PIETROWSKA M , Polanska J, Suwinski R, Widel M, et al
   Comparison of peptide cancer signatures identified by mass spectrometry in serum of patients with head and neck, lung and colorectal cancers: association with tumor progression.
   Int J Oncol. 2012;40:148-56.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
5. SHEN Y , Lu C, Tian W, Wang L, et al
   Possible association of decreased NKG2D expression levels and suppression of the activity of natural killer cells in patients with colorectal cancer.
   Int J Oncol. 2011 Dec 22. doi: 10.3892/ijo.2011.1315.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. SORIN V , Ohana P, Mizrahi A, Matouk I, et al
   Regional therapy with DTA-H19 vector suppresses growth of colon adenocarcinoma metastases in the rat liver.
   Int J Oncol. 2011;39:1407-12.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
7. AMSTERDAM A , Shezen E, Raanan C, Schreiber L, et al
   Two initiation sites of early detection of colon cancer, revealed by localization of pERK1/2 in the nuclei or in aggregates at the perinuclear region of tumor cells.
   Int J Oncol. 2011 Nov 22. doi: 10.3892/ijo.2011.1268.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
8. TOIYAMA Y , Fujikawa H, Kawamura M, Matsushita K, et al
   Evaluation of CXCL10 as a novel serum marker for predicting liver metastasis and prognosis in colorectal cancer.
   Int J Oncol. 2011 Oct 31. doi: 10.3892/ijo.2011.1247.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. LEE S , Oh T, Chung H, Rha S, et al
   Identification of GABRA1 and LAMA2 as new DNA methylation markers in colorectal cancer.
   Int J Oncol. 2011 Oct 25. doi: 10.3892/ijo.2011.1245.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. TAKEMASA I , Kittaka N, Hitora T, Watanabe M, et al
    Potential biological insights revealed by an integrated assessment of proteomic and transcriptomic data in human colorectal cancer.
    Int J Oncol. 2011 Oct 24. doi: 10.3892/ijo.2011.1244.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. CAROTENUTO P , Roma C, Cozzolino S, Fenizia F, et al
    Detection of KRAS mutations in colorectal cancer with Fast COLD-PCR.
    Int J Oncol. 2011 Oct 4. doi: 10.3892/ijo.2011.1221.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. MIYAKE M , Takemasa I, Matoba R, Tanino M, et al
    Heterogeneity of colorectal cancers and extraction of discriminator gene signatures for personalized prediction of prognosis.
    Int J Oncol. 2011;39:781-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
13. PATLOLLA JM , Zhang Y, Li Q, Steele VE, et al
    Anti-carcinogenic properties of omeprazole against human colon cancer cells and azoxymethane-induced colonic aberrant crypt foci formation in rats.
    Int J Oncol. 2011 Sep 28. doi: 10.3892/ijo.2011.1214.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. OKAZAKI S , Ishikawa T, Iida S, Ishiguro M, et al
    Clinical significance of UNC5B expression in colorectal cancer.
    Int J Oncol. 2011 Sep 15. doi: 10.3892/ijo.2011.1201.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. MIYAKI Y , Suzuki K, Koizumi K, Kato T, et al
    Identification of a potent epigenetic biomarker for resistance to camptothecin and poor outcome to irinotecan-based chemotherapy in colon cancer.
    Int J Oncol. 2011 Sep 7. doi: 10.3892/ijo.2011.1189.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
16. HAGGBLAD SAHLBERG S , Spiegelberg D, Lennartsson J, Nygren P, et al
    The effect of a dimeric Affibody molecule (ZEGFR:1907)2 targeting EGFR in combination with radiation in colon cancer cell lines.
    Int J Oncol. 2011 Aug 29. doi: 10.3892/ijo.2011.1177.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. KHELWATTY SA , Essapen S, Seddon AM, Modjtahedi H, et al
    Growth response of human colorectal tumour cell lines to treatment with afatinib (BIBW2992), an irreversible erbB family blocker, and its association with expression of HER family members.
    Int J Oncol. 2011;39:483-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. CHO YG , Chang X, Park IS, Yamashita K, et al
    Promoter methylation of leukemia inhibitory factor receptor gene in colorectal carcinoma.
    Int J Oncol. 2011;39:337-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. DREBBER U , Lay M, Wedemeyer I, Vallbohmer D, et al
    Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy.
    Int J Oncol. 2011;39:409-15.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
20. MACNAB SA , Turrell SJ, Carr IM, Markham AF, et al
    Herpesvirus saimiri-mediated delivery of the adenomatous polyposis coli tumour suppressor gene reduces proliferation of colorectal cancer cells.
    Int J Oncol. 2011 Jul 18. doi: 10.3892/ijo.2011.1130.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. MARIMUTHU S , Chivukula RS, Alfonso LF, Moridani M, et al
    Aspirin acetylates multiple cellular proteins in HCT-116 colon cancer cells: Identification of novel targets.
    Int J Oncol. 2011 Jul 4. doi: 10.3892/ijo.2011.1113.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. LEE GH , Chae HJ, Kim HR
    Monoamine carboxylate transporters are involved in BI-1-associated cancer metastasis in HT1080 colon fibrosarcoma cells.
    Int J Oncol. 2011;39:209-16.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
23. UCHIYAMA T , Takahashi H, Endo H, Sugiyama M, et al
    Role of the long form leptin receptor and of the STAT3 signaling pathway in colorectal cancer progression.
    Int J Oncol. 2011 Jun 29. doi: 10.3892/ijo.2011.1105.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. NAKAGAWA S , Miyoshi N, Ishii H, Mimori K, et al
    Expression of CLDN1 in colorectal cancer: A novel marker for prognosis.
    Int J Oncol. 2011 Jun 28. doi: 10.3892/ijo.2011.1102.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. ADAMSEN BL , Kravik KL, De Angelis PM
    DNA damage signaling in response to 5-fluorouracil in three colorectal cancer cell lines with different mismatch repair and TP53 status.
    Int J Oncol. 2011 Jun 14. doi: 10.3892/ijo.2011.1080.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. LU J , Liu K, Zhao J, Zhao J, et al
    VEGF-A not Ang2 mediates endothelial-like differentiation of immature DCs by ERK1/2 signaling in the microenvironment of human colon adenocarcinoma.
    Int J Oncol. 2011;38:1579-88.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
27. AKCAKAYA P , Ekelund S, Kolosenko I, Caramuta S, et al
    miR-185 and miR-133b deregulation is associated with overall survival and metastasis in colorectal cancer.
    Int J Oncol. 2011 May 13. doi: 10.3892/ijo.2011.1043.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. DE WEVER O , Sobczak-Thepot J, Vercoutter-Edouart AS, Michalski JC, et al
    Priming and potentiation of DNA damage response by fibronectin in human colon cancer cells and tumor-derived myofibroblasts.
    Int J Oncol. 2011 May 9. doi: 10.3892/ijo.2011.1034.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
29. YAMAGUCHI T , Kakefuda R, Tajima N, Sowa Y, et al
    Antitumor activities of JTP-74057 (GSK1120212), a novel MEK1/2 inhibitor, on colorectal cancer cell lines in vitro and in vivo.
    Int J Oncol. 2011 Apr 26. doi: 10.3892/ijo.2011.1015.
    PubMed     Text format     Related articles   
    
    
    
    
30. TANABE H , Kuribayashi K, Tsuji N, Tanaka M, et al
    Sesamin induces autophagy in colon cancer cells by reducing tyrosine phosphorylation of EphA1 and EphB2.
    Int J Oncol. 2011 Apr 18. doi: 10.3892/ijo.2011.1011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. XU C , Yang M, Tian J, Wang X, et al
    MALAT-1: A long non-coding RNA and its important 3' end functional motif in colorectal cancer metastasis.
    Int J Oncol. 2011 Apr 15. doi: 10.3892/ijo.2011.1007.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
32. YANG SY , Miah A, Sales KM, Fuller B, et al
    Inhibition of the p38 MAPK pathway sensitises human colon cancer cells to 5-fluorouracil treatment.
    Int J Oncol. 2011 Mar 21. doi: 10.3892/ijo.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. NISHIDA N , Yokobori T, Mimori K, Sudo T, et al
    MicroRNA miR-125b is a prognostic marker in human colorectal cancer.
    Int J Oncol. 2011 Mar 10. doi: 10.3892/ijo.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. SAIGUSA S , Toiyama Y, Tanaka K, Yokoe T, et al
    Cancer-associated fibroblasts correlate with poor prognosis in rectal cancer after chemoradiotherapy.
    Int J Oncol. 2011;38:655-63.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
35. VIDAL F , de Araujo WM, Cruz AL, Tanaka MN, et al
    Lithium reduces tumorigenic potential in response to EGF signaling in human colorectal cancer cells.
    Int J Oncol. 2011 Feb 28. doi: 10.3892/ijo.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. KADOTA K , Huang CL, Liu D, Yokomise H, et al
    Combined therapy with a thymidylate synthase-inhibiting vector and S-1 has effective antitumor activity against 5-FU-resistant tumors.
    Int J Oncol. 2011;38:355-63.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. ROY HK , Koetsier JL, Tiwari AK, Joshi S, et al
    Involvement of p21cip1/waf1 in the anti-proliferative effects of polyethylene glycol in colon carcinogenesis.
    Int J Oncol. 2011;38:529-36.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. HE BC , Gao JL, Luo X, Luo J, et al
    Ginsenoside Rg3 inhibits colorectal tumor growth through the down-regulation of Wnt/ss-catenin signaling.
    Int J Oncol. 2011;38:437-45.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. TSUJINAKA S , Soda K, Kano Y, Konishi F, et al
    Spermine accelerates hypoxia-initiated cancer cell migration.
    Int J Oncol. 2011;38:305-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
40. HUANG WW , Ko SW, Tsai HY, Chung JG, et al
    Cantharidin induces G2/M phase arrest and apoptosis in human colorectal cancer colo 205 cells through inhibition of CDK1 activity and caspase-dependent signaling pathways.
    Int J Oncol. 2011 Jan 24. doi: 10.3892/ijo.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. JEDINAK A , Thyagarajan-Sahu A, Jiang J, Sliva D, et al
    Ganodermanontriol, a lanostanoid triterpene from Ganoderma lucidum, suppresses growth of colon cancer cells through ss-catenin signaling.
    Int J Oncol. 2011 Jan 11. doi: 10.3892/ijo.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. ACKERMANN M , Carvajal IM, Morse BA, Moreta M, et al
    Adnectin CT-322 inhibits tumor growth and affects microvascular architecture and function in Colo205 tumor xenografts.
    Int J Oncol. 2011;38:71-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
43. LIN J , Chen Y, Wei L, Chen X, et al
    Hedyotis Diffusa Willd extract induces apoptosis via activation of the mitochondrion-dependent pathway in human colon carcinoma cells.
    Int J Oncol. 2010;37:1331-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. BELLONE G , Gramigni C, Vizio B, Mauri FA, et al
    Abnormal expression of Endoglin and its receptor complex (TGF-beta1 and TGF-beta receptor II) as early angiogenic switch indicator in premalignant lesions of the colon mucosa.
    Int J Oncol. 2010;37:1153-65.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: